[go: up one dir, main page]

WO2003043931A1 - Structures artificielles a fonctionnalite magnetique - Google Patents

Structures artificielles a fonctionnalite magnetique Download PDF

Info

Publication number
WO2003043931A1
WO2003043931A1 PCT/SE2002/002099 SE0202099W WO03043931A1 WO 2003043931 A1 WO2003043931 A1 WO 2003043931A1 SE 0202099 W SE0202099 W SE 0202099W WO 03043931 A1 WO03043931 A1 WO 03043931A1
Authority
WO
WIPO (PCT)
Prior art keywords
magnetic
particle
particles
structure according
chemical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/SE2002/002099
Other languages
English (en)
Inventor
Sven Oscarsson
Arjan P. Quist
Peter Svedlindh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to AU2002353698A priority Critical patent/AU2002353698A1/en
Publication of WO2003043931A1 publication Critical patent/WO2003043931A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16K—VALVES; TAPS; COCKS; ACTUATING-FLOATS; DEVICES FOR VENTING OR AERATING
    • F16K13/00—Other constructional types of cut-off apparatus; Arrangements for cutting-off
    • F16K13/08—Arrangements for cutting-off not used
    • F16K13/10—Arrangements for cutting-off not used by means of liquid or granular medium
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16K—VALVES; TAPS; COCKS; ACTUATING-FLOATS; DEVICES FOR VENTING OR AERATING
    • F16K31/00—Actuating devices; Operating means; Releasing devices
    • F16K31/02—Actuating devices; Operating means; Releasing devices electric; magnetic
    • F16K31/06—Actuating devices; Operating means; Releasing devices electric; magnetic using a magnet, e.g. diaphragm valves, cutting off by means of a liquid
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54326—Magnetic particles

Definitions

  • the present invention concerns artificial biological and/or biochemical structures involving magnetic functionality, and in particular such structures having sub-micron or preferably nanometer resolution.
  • the invention also concerns methods for the manufacture of such structures, their operation and use.
  • Nanotechnology plays a central role in the quest for creating artificial biologically functional surfaces.
  • lithographic and scanning probe techniques it is now possible to organise molecules onto surfaces at the nanometer scale.
  • One method describing the formation of nano-scale defects with high resolution has been disclosed in WO 99/15895 by Oscarsson et al.
  • the available techniques in themselves do however not suffice to mimic biological functions, as the flexibility at the molecular level — compared to the biological structure - is still missing, and it is yet not possible to regulate the processes as desired.
  • the published international application WO 01/22088 discloses particles having a superparamagnetic core, and their use as therapeutic agents, carrying effector molecules chosen among cytostatics, toxins, enzymes, heavy metals etc.
  • the particles are said to have a diameter of 10 nm or less, and their magnetic properties are used to direct the particle to a specific location.
  • Their use as sub-components in a bioassay is briefly mentioned but not elaborated further.
  • the application of said particles is mainly in the separation and/or concentration of desired components in a solution or reaction mixture.
  • WO 01/19405 discloses magnetic nanoparticles, and in particular magnetic nanoparticles, which can specifically bind to intracellular bio-macromolecules so that a separation can be performed by the action of an external magnetic field.
  • One application is the marking and separation and/or removal of malign cells as a step in the treatment of various forms of cancer.
  • the published international application WO 01/11360 discloses a method for detecting binding reactions through measurement of the relaxation of birefringence of magnetic nanoparticles.
  • Substances with structurally specific binding properties towards the analytes to be determined are labelled with ferri- or ferromagnetic substances, forming a magnetic complex or nanoparticle, and then added to the sample selected for analysis. After application of an external magnetic field, the relaxation of birefringence of the magnetic complexes is determined.
  • WO 97/46882 in turn discloses an apparatus and a method for separating, immobilizing, and quantifying biological substances from within a fluid medium by employing a high internal gradient magnetic capture structure formed within a vessel, in conjunction with an externally- applied force for transporting magnetically responsive material towards the capture structure.
  • Tanase M. et al., "Magnetic Alignment of Fluorescent Nanowires” in Nano Letters, 2001, Vol. 1, No. 3, 155-158 disclose the orientation of nickel nanowires in magnetic fields.
  • One objective of the present invention is to create artificial biotechnological structures with a high degree of order while retaining a flexibility that makes it possible to manipulate the structure in four dimensions.
  • a structure according to the invention should be operable not only in space, as in two or three dimensions, but also in time, e.g. activated or deactivated at a desired point in time.
  • Another objective is to create the means for investigating and developing the possible applications of, and exploring the limits of magnetic forces on a magnetic system in a liquid based environment.
  • Another, closely related objective is to create the means for investigating and developing the possible applications of and the limits of magnetic forces on a magnetic system in a two- or three-dimensional solid or semisolid environment.
  • Another objective is to create tools for the investigation of the speed and forces involved in manipulating e.g. rotating magnetic particles provided with different kinds of molecules and cells, and to investigate the forces between individual macromolecules immobilised on different magnetic particles.
  • One application is for example the determination of binding constants between individual macromolecules in a magnetic field.
  • an objective of the present invention is to make available the means and methods for the investigation of the effects of generated electromagnetic fields on cells and biological reactions, such as bioaffinity reactions.
  • an objective is to make available the means and methods for the investigation of molecular interactions in magnetic environments and/or by use of magnetic forces.
  • Yet another objective is to make available the means and methods for the investigation of fluidic dynamics in the sub-micron and nanometer ranges.
  • Yet another objective is to create functional components, which can find utility in nanomechanical applications, for example for controlled (with respect to location, movement, and time) manipulation of minute amounts of sample, analyte or even single molecules or particles.
  • the present inventors have surprisingly shown that by using externally operable magnetic elements present on a surface or below or above the same, in combination with separate magnetic particles, chemical and biochemical processes can be finely regulated down to the nanometer scale. As the magnetic elements are externally operable, a particular function can be initiated at a particular location, and at a particular time, as desired.
  • This invention makes available means and methods, which are of interest for biotechnological research, and make possible many biotechnological, medical, diagnostic as well as chemical applications. Applications of the present invention focus e.g.
  • Fig. 1 shows schematically how a magnetic microstructure consisting of a magnetic element 1 is used to manipulate magnetic particles 2 having particular surface properties, here illustrated by immobilised groups 3, thus achieving a mechanism where these properties are either displayed as shown in (b), or hidden as shown in (c) as desired.
  • the arrow "H” illustrates the external magnetic field.
  • the arrows drawn in the elements show the magnetic polarity of the elements.
  • Fig. 2 shows schematically how magnetic particles 2 are used to move macromolecules on a surface, for example between different magnetic elements 4, 5, and 6, arranged on the surface.
  • the external magnetic field is indicated with an arrow H, first pointing right, then down (FT)
  • Fig. 3 illustrates how magnetic elements can be supplemented by geometric features on a non- ' magnetic material covering the magnetic elements. Such features are used to influence the orientation or location of magnetic particles drawn to said elements, alternatively to modify the influence of the magnetic element on its surroundings, here illustrated by the flow channel formed between layers III and IV.
  • the element el is covered by a non-magnetic layer, exhibiting a locally increased thickness, a local hillock or raised area above the element; in (b) the non-magnetic is thinner or exhibits a hole, locally above element e2; in (c) the nonmagnetic layer is thicker in an area, larger than the size of the underlying magnetic element e3.
  • the layers I, II, III, and IN illustrate a substrate and non-magnetic layers respectively, defining the geometry of the device in which the elements are incorporated.
  • Layers I, II, III, and IN can be manufactured of the same or different materials, preferably a thermoplastic material.
  • Fig. 4 illustrates how features of the substrate can be utilised to influence the deposition of the magnetic film and thus to form magnetic elements of different configuration, as well as discontinuities in an otherwise magnetic surface, "s” denotes a substrate, and "m” denotes the magnetic layer.
  • the substrate s can consist of several layers (not shown).
  • Fig. 5 illustrates schematically how magnetic elements positioned along a flow channel can be used to influence components present in a flow, passing said elements, e.g. a liquid flow in a flow channel defined by layers of non-magnetic material.
  • the element el is activated in order to make the particles magnetically immobilised thereto expose their functional groups; element e2 is given an opposite polarity in order to make similar particles hide their functional groups; element e3 is activated in order to capture magnetic particles from the flow of liquid; and e4 is deactivated in order to release previously captured particles.
  • Fig. 6 illustrates in (a) how one or more magnetic particles can be used to stir a liquid in a miniature flow cell, and (b) how a magnetic particle can be used to create a miniature valve, directing the flow in small passages.
  • a magnetic element A By externally activating or by externally changing the polarity of a magnetic element A, positioned within effective reach of the particles, e.g. below, above, or alongside the flow cell, the movement of a particle or particles p is controlled.
  • the movement of the particle from a "closed” to an "opened” postion of the valve, and vice versa, is achieved by one or more magnetic elements, here shown as B and C, positioned alongside, below or above the passage.
  • the particle p When the magnetic element B is activated, using an external magnetic field, and its polarity properly adjusted, the particle p is immobilised adjacent to the wall of the passage, next to B, and the valve kept open. When B is inactivated, or its polarity reversed, and C correspondingly activated, and its polarity properly adjusted, the particle p is drawn to a position where it closes the valve.
  • Fig. 7 a illustrates schematically how a magnetic particle with a particular property, such as hydrophobicity / hydrophilicity or the presence / absence of a macromolecule, such as a particular ligand, can be rotated within a small chamber, and e.g. used to transport minute amounts of a substance from one compartment to another in miniaturized flow systems.
  • the position of the particle is operated using one or more magnetic elements (not shown), activated / deactivated by corresponding external magnetic fields.
  • the particle is contained in a constriction in a channel, said constriction defining a compartment holding the particle, but not restricting its movements.
  • Fig. 7 b shows a perspective view of such constriction. Description
  • nanoparticle meaning one billionth (1/1,000,000,000) has here been used in combination with various nouns, defining their properties, as in the word “nanoparticle”. This term is used for describing particles having an average diameter of 100 nm or less.
  • nanostructure and “nanometer resolution” defines structures having features having an average size of 100 nm or less in at least one dimension.
  • micron resolution defines structures of size approximately 1 micrometer, while sub-micron resolution defines a structure having an average diameter in the interval 0.1 to 1 micrometer.
  • array also defines an ordered distribution of features, in contrast to random or unordered features.
  • each feature is identified by its location, its coordinates within the array.
  • Normally arrays are patterns arranged in rows and columns, both also other formats can be envisioned, provided that the unique coordinates of each feature can be identified.
  • chemical or biochemical property is used to define properties such as affinity or repulsion, binding properties, hydrophilic / hydrophobic properties, specific reactions between ' chemical entities, between a particle and a chemical entity, between a particle and a cell, between cells, between chemical entities and cells, such as the reaction between enzyme and substrate, between catalysts and reactants, between enzymes and cofactors, between antibody and antigen etc.
  • the term "chemical or biochemical reactions” meant to encompass all chemical and biochemical reactions where it is desirable to regulate or enhance the behaviour of components on or in the vicinity of surfaces, and in particular minute amounts of such components, such as substrates, analytes, ligands, reagents, receptors, cofactors etc. in chemical and biochemical synthesis, analysis, assays etc.
  • receptor comprises all types of receptors, such as membrane bound receptors, soluble receptors, lectins, antibodies, fragments of antibodies, peptides, and synthetic receptor molecules.
  • analyte is used in a broad sense of the word, encompassing any chemical entity to be handled or determined for chemical, biochemical, diagnostic or therapeutic purposes.
  • reaction vessel when used in this context means any vessel capable of containing a reaction mixture of interest.
  • reaction vessels suitable for use according to the invention include, but are not limited to, the following: test tubes, so called micro tubes, Eppendorf-tubes, a single well or a multitude of wells in a microtitre plate, such as a microtitre plate of the 96-hole format, and various formats with a high density arrays of wells, such as the 192-hole format, the 384-hole format, denser formats or the like.
  • test tubes so called micro tubes
  • Eppendorf-tubes a single well or a multitude of wells in a microtitre plate, such as a microtitre plate of the 96-hole format
  • various formats with a high density arrays of wells such as the 192-hole format, the 384-hole format, denser formats or the like.
  • One aspect of the invention is the production of functional components, which can be applied in such reaction vessels, or integrated therein.
  • a preferred embodiment of the invention is however the application of the invention to miniaturized reaction vessels, including flow cells, flow channels, cells and volumes, defined in platforms and devices of various formats, such as a disc or other device, e.g. the analysis platform corresponding to the conventional CD-format.
  • the present inventors here make available a three-dimensional structure having micron • resolution, and preferably sub-micron resolution and magnetic functionality, preferably with a nanometer resolution, wherein said structure comprises a first element being a substrate having a magnetic film deposited thereon, and a second element being at least one separate magnetic element with an associated chemical or biochemical property.
  • Said first element is a magnetic element, e.g. a thin magnetic film deposited on an otherwise non-magnetic substrate.
  • said first magnetic element is externally operable, meaning that it can be activated or deactivated, and its magnetic polarity adjusted as desired, by application of an external magnetic field.
  • Suitable magnetic materials include soft magnetic materials, such as Fe, Fe-Si alloys, , Ni-Fe alloys, Ni-Fe-Cu-Cr alloys etc.
  • Preliminary experiments indicate that the thickness of the magnetic film or magnetic element preferably is in the interval of 20 to 50 nm.
  • said magnetic element is of a size which guarantees that said element in zero external field comprises at least four magnetic domains.
  • said element is a rectangular element comprising four magnetic domains, or a higher amount of magnetic domains, however an amount of domains forming a closed magnetic circuit when the element is not exposed to an external magnetic field.
  • the geometry of the element may be varied, that is the element can have other shapes than rectangular.
  • Rectangular in this context also comprises bar shaped elements, embedded into a substrate, or protruding therefrom, exposing either their long side or short side to the surface. Exposing can also mean that the short or long side of the element is present slightly below the surface, or slightly above, in the inverted case, where the surface in question e.g. defines the ceiling of a channel or compartment.
  • the shape of the element can, according to the invention, be used to influence the formation of -magnetic domains.
  • the magnetic element can be square, rectangular, circular, elliptic.
  • the magnetic element can surprisingly also be formed as a discontinuity in a magnetic film, e.g. a hole in a magnetic film, deposited on an otherwise non-magnetic substrate.
  • the magnetic elements can also be shaped as a ring or donut, as well as the corresponding negative images thereof.
  • a magnetic element can also be shaped as a raised or lowered subsection in a substrate. It is also conceived, and constitutes an aspect of the invention, that the magnetic element may be present in combination with a non-magnetic structure, which canalises or otherwise orientates the particles. In other words, a discontinuity can be used to define a magnetic element.
  • Embodiments of this particular aspect of the invention comprises non-magnetic layers superimposed on the magnetic elements, said layers having features, such as depressions, rises, ridges, etc which aid in the positioning and optionally determine he orientation of the magnetic particles. See Fig. 3.
  • the magnetic polarity in the centre of the circular elements can perpendicular to the plane, either directed inwards, into the plane, or outwards, out of the plane.
  • the second element is a magnetic particle, that is a particle small enough to exhibit a mono-domain magnetic state, but still large enough to exhibit a stable particle magnetic moment, and preferably of a size in the interval of less than about 500 nm, preferably less than 300 nm and most preferably less than 100 nm.
  • Said particle preferably has a magnetic core covered by a non-magnetic shell, e.g. a dextran shell, which aids in the immobilisation of functional groups etc to the particle.
  • a non-magnetic shell e.g. a dextran shell
  • the magnetic particles are provided with an external property, other than their magnetic property. See particle 2 in Fig. 1.
  • This can consist of different physical or chemical properties of the surface of the particle, such as its reflectance, absorption, adhesion properties, affinity for a particular chemical species, hydrophobicity / hydrophilicity, immobilised macromolecules such as antibodies, substrates, enzymes, co-factors, catalytically active components, etc.
  • said particles Preferably said particles have one of the above properties on only one hemisphere, the other hemisphere exhibiting another property, or at least the absence of the property on the opposing hemisphere.
  • said hemispheres exhibiting different properties are oriented in correspondence to the magnetic polarity of the particle.
  • the "north" hemispheres has one property over its surface, whereas the "south” hemisphere lacks this property or exhibits a different property over its surface.
  • One aspect of the invention is a method for their production outlined in the following:
  • Single domain, stable magnetic cores are given a shell suitable for the desired treatment.
  • a shell of a thermoplastic resin is suitable.
  • the particles are then evenly distributed on surface and both oriented with the aid of a magnetic field.
  • the particles are subjected to a treatment resulting in the desired property being localised to the exposed hemisphere only.
  • the hydrophobic properties can be influenced.
  • a thin metallic layer is sputtered or evaported on the exposed hemisphere of the particles.
  • said first element consists of a substrate having magnetic features exhibiting micron or sub-micron resolution, such as a magnetic or magnetizable film applied in an ordered pattern on a surface.
  • Fig. 4 shows an example where a magnetic film has been applied to a patterned surface, shown in cross section. The surface pattern can be designed so, that the transition between higher and lower parts is very steep. As a consequence of this, the layer of magnetic material will be unevenly deposited when e.g. sputtered or evaporated onto the surface.
  • the magnetic material layer will be thinner at the slanted portions, and thicker at the horizontal portions. As material can be evenly removed, e.g. by etching, this means that all material can be removed from the slanted portions, leaving a magnetic layer only at the horizontal area. This makes it possible to create said features, discontinuities etc mentioned above.
  • the present invention also makes available a method for the manufacture of sub-micron three- dimensional structures comprising a substrate and means having magnetic functionality, wherein a magnetic film is arranged on the substrate in a pattern with sub-micron resolution, said pattern corresponding to the intended functionality of the structure, and magnetic particles are coupled to chemically functional groups, and brought in contact with said pattern on said substrate.
  • the present invention further makes available a method for operating sub-micron functional means including a structure as disclosed in the description and examples, wherein an external magnetic field is applied to the structure in order to alter the direction of the magnetic moment of at least one of the elements of the pattern of the surface, or in order to manipulate the position, orientation or movement of at least one of the magnetic particles.
  • a nanostructured magnetic pattern can for instance consist of bar shaped soft magnetic elements of e.g. permalloy of size a few tenths of a micron, separated from each other by a distance, e.g. a distance in the range 0.1 - 1 ⁇ m.
  • the size of each magnetic element is large enough to exhibit a multi-domain magnetic microstructure.
  • the magnetic microstructure should correspond to that of a closed magnetic structure, that is the magnetizations in different domains should in zero field form a closed magnetic circuit (Fig- 1 (a))-
  • a magnetic colloid will be used to attach macromolecules to the surface of magnetic particles, preferably nanoparticles of size a few tens of a nanometer.
  • the size of each nanoparticle is small enough to exhibit a mono-domain magnetic state, still large enough to exhibit a stable particle magnetic moment, meaning that superparamagnetic relaxation should be negligible.
  • the magnetic nanoparticles will be attracted to the poles of the bar shaped magnets, cf. Fig. 1 (b) where an applied magnetic field has magnetised the elements to saturation, thereby immobilizing the macromolecules (magnetic nanoparticles). It is also possible to rotate the particles, thereby turning a process on or off, transporting or transposing bound particles, cells or macromolecules by changing the direction of the applied field (cf. Fig. 1 (c)).
  • Embodiments of the invention consequently comprise means and methods for exposing and manipulating cells, particles and macromolecules.
  • the orientation of the macromolecule can be regulated by magnetic forces, e.g. in order to expose different parts, such as active sites, binding sites etc of the macromolecule.
  • a macromolecule such as a polypeptide or an oligonucleotide can be stretched, contracted, folded or straightened at will.
  • a series of magnetic elements are arranged on a surface, defining a path for transporting magnetic particles.
  • the magnetic elements can be individually activated by application of an external magnetic field.
  • the elements may possess • three different states; left-hand polarity, right-hand polarity or a neutral, non-polarized state.
  • By individually activating the elements, and by changing their polarity magnetic particles can be transported along the path formed by said elements.
  • three immobilised elements when only the first has been activated,. and given a right-hand polarity, particles are drawn to the left end of said element.
  • the second element has been activated, and the polarity of the first element inverted (if necessary), the particles are drawn to the gap between said first and second element.
  • Fig. 3 features of a nonmagnetic material, superimposed on the magnetic elements, is used to direct, e.g. to focus the particles to the elements.
  • el, e2 and e3 denote separate magnetic elements on a substrate I.
  • the magnetic elements are separated by a non-magnetic material II. Further, the magnetic elements are covered by a second non-magnetic material III. Naturally nl and n2 can be the same. In a, said non-magnetic material forms a discrete hill above the magnetic element el. In b, a hole is provided in the non-magnetic material, right above the element e2, and in c, a raised surface is provided above the element e3.
  • Fig. 4 it is shown how the magnetic elements can be formed on a non-magnetic substrate having a geometry which influences the application of the magnetic film, e.g. when such film is sputtered on a surface, followed by etching to remove the materials in particular areas, relying on the phenomena that the sputtered film is deposited mainly on the flat surfaces, and that the film adhering to the slanted surfaces can be removed by etching, leaving a sufficient thickness of film in the plane areas.
  • Fig. 5 illustrates an embodiment where magnetic elements el, e2, e3, and e4 are placed in association to a flow channel.
  • Elements el and e2 both engage magnetic particles having a particular property or a functional group on one hemisphere, and another property or the absence of said property on the opposite hemisphere.
  • the magnetic particles are made to expose their property, e.g. exposing functional groups interacting with a component in the flow of samples etc passing in the flow channel.
  • element e2 its polarity has been adjusted so, that the magnetic particles are hiding their functional group or particular property, and thus unable to interact with components in the flow.
  • Element e3 has been activated, and its polarity adjusted so, that it attracts magnetic particles present in the flow. Conversely, element e4 has been inactivated, so that it releases magnetic particles formerly immobilised on its surface.
  • the magnetic elements have been shown as arranged at the "bottom" of the flow channel. It is however understood that the flow channel can be freely rotated, and the magnetic elements thus positioned above, or alongside the flow.
  • Fig. 6 illustrates two embodiments of the invention, (a) showing how one or more magnetic particles can be used to stir a liquid in a miniature flow cell, and (b) how a magnetic particle can be used to create a miniature valve, directing the flow in small passages.
  • the external magnetic field operating the particles can be created in different ways, for example using miniature solenoids placed around, below, above or to the side of the flow cell or the passage.
  • a magnetic element A is shown as being positioned below or alongside (dashed lines) the flow cell.
  • FIG. 6b two magnetic elements B and C are shown, positioned above or below the valve.
  • the magnetic element B is activated, using an external magnetic field, and its polarity properly adjusted, the particle p becomes temporarily immobilised adjacent to the wall of the passage, next to B, and the valve kept open.
  • B is inactivated, or its polarity reversed, and the magnetic element C correspondingly activated, and its polarity properly adjusted, the particle p is drawn to a position where it closes the valve.
  • Fig. 7a illustrates schematically an embodiment, where a magnetic particle is localized between two defined volumes, e.g. two compartments in a miniaturized analysis platform.
  • a magnetic element below, above, or otherwise positioned so that it can influence the orientation of said magnetic particle, is a magnetic element (not shown).
  • the magnetic particle preferably has one functionality, such as hydrophobical properties or one type of functional groups associated with or attached to one hemisphere, and another functionality / other groups, or the absence of such functionality or groups at the opposite hemisphere.
  • the orientation of the magnetic particle is influenced.
  • a magnetic particle carrying receptors for a particular compound can be used to detect the presence of said compound in one of the compartments to which a sample is led, and then recharged in the opposite compartment, containing e.g. a buffer solution or rinse solution where said compound is absent.
  • the adhesion of the compound to be determined to the magnetic particle can be detected by observing changes in movement, rotation or magnetic responsiveness of said magnetic particle.
  • Fig. 7b shows a perspective view of the above embodiment.
  • Structured magnetic surfaces can be prepared using different types of lithography. For structures down to micrometer level photolithography is used. A photoresist is spinned onto the surface, after which the surface is illuminated through a mask (prepared in advance using a CAD program and mask generator) containing the structures of interest. The resist is developed, removing the exposed parts. Next, magnetic or magnetizable material can be evaporated or sputtered onto the surface before lifting off the remaining resist.
  • fine patterns can be written, using the electronbeam of a Scanning Electron Microscope (SEM) into a polymer resist that is spinned onto the surface.
  • SEM Scanning Electron Microscope
  • Patterns are designed in a CAD program, after which the external PC simultaneously controls the x-y scan coils and beam blanker of the SEM through an interface. Exposure doses can be adjusted by varying the exposure time and/beam current, and are chosen to break the polymer bonds (positive resist, or to crosslink them at higher dose, negative resist).
  • Samples are developed in order to remove the exposed resist, after which the desired magnetic or magnetizable material can be deposited by evaporation/sputtering. Subsequent lift-off will result in a surface with sub-micron or even nanometersized structures of the evaporated material.
  • stamps which are prepared by casting pre-polymer against a master produced by conventional lithography.
  • stamps which are prepared by casting pre-polymer against a master produced by conventional lithography.
  • suitable methods applicable to the manufacture of magnetic surfaces and patterned magnetic surfaces according to the invention include the following methods:
  • Near-Field Phase Shift Lithography A transparent polydimethylene siloxane (PDMS) phase mask with relief on its surface is placed in conformal contact with a layer of photoresist. Light passing through the stamp is modulated in the near-field. If the relief on the surface of the stamp shifts the phase of light by an odd multiple of ⁇ , a node in the intensity is produced. Magnetic features with dimensions between 40 and 100 nm are produced in photoresist at each phase edge.
  • PDMS polydimethylene siloxane
  • a PDMS stamp is cast against a conventionally patterned master. Polyurethane is then molded against the secondary PDMS master. In this way, multiple copies can be made without damaging the original master.
  • the technique can replicate features as small as 30 nm.
  • MIMIC Micromolding in Capillaries
  • a PDMS stamp is filled with a prepolymer or ceramic precursor having the desired magnetic or magnetizable properties and placed on a substrate. The material is cured and the stamp is removed. The technique generates features as small as 250 nm and is able to generate multilayer systems.
  • Solvent-assisted Microcontact Molding A small amount of solvent is spread on a patterned PDMS stamp and the stamp is placed on a polymer, such as photoresist. The solvent swells the polymer and causes it to expand to fill the surface relief of the stamp. Features as small as 60 nm have been produced.
  • Microcontact Printing An "ink” of alkanethiols is spread on a patterned PDMS stamp. The stamp is then brought into contact with the substrate, which can range from coinage metals to oxide layers. The thiol ink is transferred to the substrate where it forms a self-assembled monolayer that can act as a resist against etching. Features as small as 300 nm have been made in this way.
  • One practical method of creating discrete magnetic elements on a surface, displaying high resolution is based on the contact moulding of thermoplastic surfaces against a master copy.
  • the resulting surface, displaying a pattern of raised and depressed areas is then subjected to sputtering, whereby a layer of magnetic material is deposited on the surface.
  • Surplus material is removed by chemical etching, leaving the desired pattern of discrete magnetic elements.
  • the magnetic elements can be covered in further layers of thermoplastic, the layers defining a desired geometry, such as compartments, flow channels etc.
  • Such compartments and flow channels can then be given desired chemical properties, for example by including reagents etc in said compartments / channels.
  • this is a preferred method for manufacturing miniaturized platforms for chemical and biochemical analysis.
  • magnetic nanometer sized beads or bars are partly derivatised, that is functional molecules or moieties are added only to a limited area of the bead or bar, for example to one hemisphere of a bead or to half the circumference of a cylindrical bar.
  • This partial derivatisation is done by using evaporisation of different metals (e.g. gold) or chemicals (e.g. silanols) on beads or bar shaped particles when they are immobilised (e.g magnetically) to a surface. This makes it possible to immobilise different molecules with different chemical characteristics to different regions of the magnetic particles.
  • the final result can for example be that one hemisphere of a bead is coated with hydrophobic molecules, the opposite side is hydrophilic or one side of a molecule is coated with one kind of cell/biomolecule/molecule, and the opposite side is coated with another kind of cell/biomolecule/molecule.
  • catalytic parts for chemical reactions can be immobilised on one side of the magnetic particles and inhibitors or "nothing" on the other side.
  • Cells could be immobilised on one side, which will make it possible to move the cells, e.g. from one compartment to another for regulation of activity.
  • One aspect of the invention is its use in applications relating to fluid dynamics.
  • the flow of liquid in micro- or nano-fluidic systems is regulated by use of magnetic beads operated using magnetic elements, activated by external magnetic fields.
  • the beads will serve as a "tap" at constrictions of the fluidic system forming controllable valves which make it possible to regulate liquid flow also in very small scale devices where regulation of the movement, dispensing or flow of chemicals or biological molecules is of importance.
  • Particular embodiments include, but are not limited to drug release systems for in vivo or in situ use, regulators of devices dispensing reagents for chemical reactions.
  • Magnetic beads according to the present invention can also be used for stirring liquids in small compartments, for closing liquid/surface interfaces or for moving the beads close to the surface of tubes for cleaning procedures.
  • one or more magnetic beads is/are provided with antibodies and placed in a small constriction or compartment where at least one bead can be subjected to an analyte and made to move, rotate, oscillate or vibrate in said constriction. The movement, rotation or the like will continue as long as there is no biospecific reaction between the analyte and the antibody. Changes in movement, e.g. rotation, are then detected and taken as an indication that the antibody has reacted with its counterpart.
  • Another aspect of the present invention is the application of the invention to catalytic systems.
  • Molecules of different molecular weights are possible to immobilise to magnetic colloids such as porphyrin molecules and analogs useful for metal organic catalysis of industrially important processes.
  • Such heterogenous organic catalysis make it possible to let a reaction take place with the catalysator immobilised to the nanomagnetic beads in a bulk solution and to regulate, e.g. increase the molecular transportation by stirring the catalysator during the reaction, and finally to attract the particles e.g. to the magnetic elements of a surface which separate the catalytic unit from the products in an efficient way.
  • the invention can be used to regulate ON/OFF mechanisms for chemical reactions where catalyst molecules are involved.
  • the catalytic unit is positioned on one side of the hemisphere of a nanometer sized magnetic bead or on one side of a bar shaped magnetic particle, preferably a nanoparticle. By rotating the magnetic particles the catalyst will be exposed to the bulk solution or be sterically hindered from reaction.
  • Yet another aspect of the present invention is the application of the invention to biocatalytic systems.
  • biocatalytic systems often are regulated by cofactors
  • the present invention makes it possible to regulate biochemical reactions with high accuracy and precision by moving magnetic particles immobilised with enzymes into compartments provided with the necessary cofactors.
  • Another aspect of the present invention is the application of the invention to hydrophobic/hydrophilic surfaces or to ion exchange surfaces.
  • magnetic beads or bars partly derivatised with one kind of molecule on one side and another one on the opposite side the possibility exist to create a surface by which e.g. the property of said surface could be changed by rotating the magnetic particles on the surface. Applying this principle, different gradients of hydrophobicity can be created for a surface.
  • one side of the surface can be an ion exchanger.
  • Another aspect of the invention is the application of the inventive technology to applications where the desired functionality / property is one of absorption, reflection, or transmission of infrared, visible or ultraviolet radiation. Since the magnetic particles in the form of magnetic bars are possible to rotate at will, the efficiency of molecules absorbing incident light or vice versa can be regulated. This can be used e.g. for regulating the sensitivity or efficiency of solar cells.
  • Cells in this context means both eukaryotic and prokaryotic cells, including organelles and cell fragments. Also viral particles and their fragments are included.
  • the present invention makes it possible to organise and directly distribute or spread e.g. cells on surfaces by using cell growth stimulating factors immobilised to magnetic beads.
  • One important embodiment is the stimulation of nerve cell growth on magnetic surfaces.
  • immobilisation of cells to magnetic beads of nanometer dimensions makes it possible to change the position of cells and in this way regulate their activity by moving, adjusting or removing the magnetic particles.
  • One aspect of the invention concerns biomolecular motors.
  • the possibility to position and move magnetic beads on surfaces, said beads having biomolecules immobilised onto them, makes it possible to create new artificial biological and biomechanical structures, as well as to investigate the functions of such structures.
  • One embodiment is the creation of artificial respiratory chains or enzyme cascades, e.g. for generation of proton gradients or voltage.
  • Another aspect of the invention relates to the creation of ordered arrays of molecules, particles, cells or organelles on a surface.
  • One example is the creation of nucleic acid and protein arrays.
  • magnetic particles are derivatised with a component having affinity to the chosen molecules, particles, cells or organelles that are to be arrayed with different kinds of antibodies/DNA templates.
  • a first array of magnetic elements is then arranged on or within a surface.
  • Said array of magnetic elements is then magnetised at sitespecific areas, that is one or several of the magnetic elements is/are magnetised as desired.
  • Magnetic particles with one kind of antibody will then be directed to the desired positions and the procedure repeated for other sets of magnetic particles derivatised with other molecules, particles, cells or organelles. By further repeating this procedure, magnetic particles carrying different molecules, particles, cells or organelles will be site specifically positioned on the surface in the form of an ordered array.
  • the array can have "built in" functionalities, for example in that a sub-group of the particles immobilised on the magnetic elements on the surface can be manipulated. By changing the polarity of selected magnetic elements, chosen particles can be repelled from the surface, or their orientation changed as desired.
  • One specific embodiment is a flexible ordered array, i.e. an ordered array, in which individual locations or groups of locations can be addressed, and their properties manipulated. Addressed and manipulated in this context means not only that molecules, particles, cells or organelles can be immobilised at specific locations or coordinates as desired, but also that they can be turned in their positions, activated or deactivated or released or even repelled from their positions as desired.
  • Immunocomplexes formed in solution outside the surface together with a marker molecule are then added to the surface and immobilised biospecifically via the antibody. Washing the surface eliminates the possible excess of marker. The local position of the marker will then give information as to what kind of analyte was present in the sample.
  • Another aspect of the present invention is the possibility to produce novel diagnostic devices and instruments for research and analysis.
  • the present invention makes available the methods and devices for the construction of diagnostic devices.
  • One embodiment of the invention is a device for the determination of blood glucose levels, preferably combined with glucose oxidase for detection and regulation of the concentration of sugar in blood. Examples
  • an array of 500.000 magnetic elements was constructed on a silicon substrate.
  • the 500.000 magnetic elements were evenly distributed in rows and columns over an area of 2 x 2 mm.
  • an even activation of the elements was observed.
  • magnetic particles, preferably magnetic nanoparticles to this array of magnetic elements, an even immobilisation of said particles on said area was achieved.

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Mechanical Engineering (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Thin Magnetic Films (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

L'invention concerne une structure présentant une fonctionnalité magnétique comprenant au moins un élément magnétique ayant une position fixe, dans laquelle ledit élément fixe est un élément magnétique, dont la polarité magnétique peut être réglée par l'application d'un champ magnétique extérieur, et un second élément étant au moins un élément magnétique mobile séparé présentant une propriété chimique ou biochimique associée. De préférence, lesdits éléments magnétiques comprennent une couche mince magnétique déposée sur un substrat en motifs, correspondant à la fonctionnalité voulue de la structure, et d'une taille telle que chaque élément dudit motif est suffisamment grand pour présenter une microstructure magnétique multidomaine. De préférence, ledit élément magnétique séparé est d'une taille telle que chaque particule est suffisamment petite pour présenter un état magnétique mono-domaine, tout en étant assez grande pour présenter un moment magnétique de particule stable.
PCT/SE2002/002099 2001-11-20 2002-11-19 Structures artificielles a fonctionnalite magnetique Ceased WO2003043931A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002353698A AU2002353698A1 (en) 2001-11-20 2002-11-19 Artificial structures with magnetic functionality

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0103859-5 2001-11-20
SE0103859A SE0103859D0 (sv) 2001-11-20 2001-11-20 Novel artificial structures with magnetic functionality

Publications (1)

Publication Number Publication Date
WO2003043931A1 true WO2003043931A1 (fr) 2003-05-30

Family

ID=20286040

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/SE2002/002099 Ceased WO2003043931A1 (fr) 2001-11-20 2002-11-19 Structures artificielles a fonctionnalite magnetique

Country Status (3)

Country Link
AU (1) AU2002353698A1 (fr)
SE (1) SE0103859D0 (fr)
WO (1) WO2003043931A1 (fr)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005083057A1 (fr) * 2004-03-01 2005-09-09 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Manipulation magnetique d'echantillons biologiques
DE102005018778A1 (de) * 2004-11-22 2006-05-24 Perea Saavedra, Héctor, Dipl.-Ing. Verfahren zur Erzeugung einer ein- oder mehrdimensionalen aus Einheiten bestehenden Struktur sowie nach dem Verfahren erzeugte Struktur
EP1811040A1 (fr) * 2006-01-23 2007-07-25 Siemens Aktiengesellschaft Dispositif et procédé pour détecter un analyte
WO2009074692A2 (fr) 2007-12-13 2009-06-18 Sven Oscarsson Dérivatisation partielle de particules
US20130338481A1 (en) * 2003-04-15 2013-12-19 Koninklijke Philips N.V. Device and method for examination and use of an electrical field in an object under examination containing magnetic particles

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997046882A1 (fr) * 1996-06-07 1997-12-11 Immunivest Corporation Separation magnetique au moyen de gradients externes et internes
WO2000054882A1 (fr) * 1999-03-15 2000-09-21 Aviva Biosciences Corporation Puces a reseaux d'unites micro-electromagnetiques adressables individuellement
JP2001132861A (ja) * 1999-11-05 2001-05-18 Ebara Corp 微小バルブ
WO2001057506A1 (fr) * 2000-02-04 2001-08-09 The United States Of America As Represented By The Secretary Of The Navy Capteur magnetique puissant pour particules magnetiques
WO2002012896A1 (fr) * 2000-08-08 2002-02-14 Aviva Biosciences Corporation Techniques de manipulations de fragments dans des systemes microfluidiques
WO2002097422A1 (fr) * 2001-05-31 2002-12-05 Electron-Bio, Inc. Dispositif microvalve a microbille et son mode de commande

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997046882A1 (fr) * 1996-06-07 1997-12-11 Immunivest Corporation Separation magnetique au moyen de gradients externes et internes
WO2000054882A1 (fr) * 1999-03-15 2000-09-21 Aviva Biosciences Corporation Puces a reseaux d'unites micro-electromagnetiques adressables individuellement
JP2001132861A (ja) * 1999-11-05 2001-05-18 Ebara Corp 微小バルブ
WO2001057506A1 (fr) * 2000-02-04 2001-08-09 The United States Of America As Represented By The Secretary Of The Navy Capteur magnetique puissant pour particules magnetiques
WO2002012896A1 (fr) * 2000-08-08 2002-02-14 Aviva Biosciences Corporation Techniques de manipulations de fragments dans des systemes microfluidiques
WO2002097422A1 (fr) * 2001-05-31 2002-12-05 Electron-Bio, Inc. Dispositif microvalve a microbille et son mode de commande

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Week 200148, Derwent World Patents Index; Class B04, AN 2001-445832 *

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130338481A1 (en) * 2003-04-15 2013-12-19 Koninklijke Philips N.V. Device and method for examination and use of an electrical field in an object under examination containing magnetic particles
US11045107B2 (en) * 2003-04-15 2021-06-29 Koninklijke Philips N.V. Device and method for examination and use of an electrical field in an object under examination containing magnetic particles
WO2005083057A1 (fr) * 2004-03-01 2005-09-09 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Manipulation magnetique d'echantillons biologiques
KR100801518B1 (ko) * 2004-03-01 2008-02-12 프라운호퍼-게젤샤프트 추르 푀르데룽 데어 안제반텐 포르슝 에 파우 생물학적 샘플의 자기 조작
US8241906B2 (en) 2004-03-01 2012-08-14 Fraunhofer-Gesellschaft Zur Forderung Der Angewandten Forschung E.V. Magnetic manipulation of biological samples
DE102005018778A1 (de) * 2004-11-22 2006-05-24 Perea Saavedra, Héctor, Dipl.-Ing. Verfahren zur Erzeugung einer ein- oder mehrdimensionalen aus Einheiten bestehenden Struktur sowie nach dem Verfahren erzeugte Struktur
DE102005018778B4 (de) * 2004-11-22 2010-05-06 Perea Saavedra, Héctor, Dipl.-Ing. Verfahren zur Erzeugung einer ein- oder mehrdimensionalen aus Einheiten bestehenden Struktur sowie nach dem Verfahren erzeugte Struktur
EP1811040A1 (fr) * 2006-01-23 2007-07-25 Siemens Aktiengesellschaft Dispositif et procédé pour détecter un analyte
US8263331B2 (en) 2006-01-23 2012-09-11 Siemens Aktiengesellschaft Device and method for the detection of an analyte
WO2009074692A2 (fr) 2007-12-13 2009-06-18 Sven Oscarsson Dérivatisation partielle de particules
WO2009074692A3 (fr) * 2007-12-13 2009-11-12 Sven Oscarsson Dérivatisation partielle de particules
US9389226B2 (en) 2007-12-13 2016-07-12 Lab-On-A-Bead Ab Partial derivatization of particles

Also Published As

Publication number Publication date
SE0103859D0 (sv) 2001-11-20
AU2002353698A1 (en) 2003-06-10

Similar Documents

Publication Publication Date Title
Qin et al. Soft lithography for micro-and nanoscale patterning
Whitesides et al. Soft lithography in biology and biochemistry
Falcaro et al. Patterning techniques for metal organic frameworks
Folch Introduction to bioMEMS
Kim et al. Biomimetic nanopatterns as enabling tools for analysis and control of live cells
US7285412B2 (en) Device for magnetic immobilization of cells
Bowden et al. Self-assembly of microscale objects at a liquid/liquid interface through lateral capillary forces
Sharma et al. Unconventional low-cost fabrication and patterning techniques for point of care diagnostics
Ogaki et al. Chemical patterning in biointerface science
KR20000069528A (ko) 회절 상을 만드는 바이오감지 장치
Ng et al. Biochips beyond DNA: technologies and applications
Wang et al. Single-cell patterning technology for biological applications
US8034609B2 (en) Ablation based laser machining of biomolecule patterns on substrates
Shim et al. Micro-and nanotechnologies for studying cellular function
Bhatt et al. Surface patterning techniques for proteins on nano-and micro-systems: a modulated aspect in hierarchical structures
WO2003043931A1 (fr) Structures artificielles a fonctionnalite magnetique
US20120299221A1 (en) Magnetic reversibly attached template (mrat) and uses therefor
Bompart et al. Micro and nanofabrication of molecularly imprinted polymers
Kang et al. Poly (ethylene glycol)(PEG) microwells in microfluidics: Fabrication methods and applications
Hahm Polymeric surface-mediated, high-density nano-assembly of functional protein arrays
Kane et al. Soft lithography and microfluidics
Fritz et al. Microcontact printing of substrate-bound protein patterns for cell and tissue culture
Han et al. Lipid bilayer membrane arrays: fabrication and applications
KR100722321B1 (ko) 모세관력 리소그래피와 자기조립단분자막을 이용한 단백질패턴 형성 방법 및 이를 이용하여 제조된 단백질칩
WO2003074659A2 (fr) Immobilisation magnetique de cellules

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP